Will you invest in Covid-19 stocks now?

Detail IM：

【BioCardia Announces FDA Approval of its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19】

Related Stock:BCDA

Source:news from Ainvest-app